Dr. James Kyle Bryan is chief medical officer for IQVIA Biotech Clinical Solutions. He has more than 20 years of experience in drug discovery and development in the pharmaceutical and biotechnology industries in both the sponsor and CRO arenas.
Dr. Bryan provides medical and safety leadership to all clinical projects as well as bringing valuable insights into clinical development and regulatory strategy to our clients.
Dr. Bryan is board-certified in medical oncology and hematology, and remains engaged in clinical work, holding an appointment on the clinical faculty of medicine for hematology and oncology at the University of Washington Medical Center. Previously, Dr. Bryan served as chief medical officer for VentiRx Pharmaceuticals and vice president of medical affairs for Seattle Genetics.
Kyle holds a bachelor’s degree in Biochemistry and an MD from Louisiana State University. He completed his fellowship in hematology and oncology at the University of Washington.